While there is still time to enjoy the last month of summer, here are the latest opportunities in the IP field.
Assimilate IP
 |
| Image via Pexels |
Assimilate IP is offering a series of training courses given by webinar and IPKat readers are very welcome to a 10% discount on the registration fees by adding ‘IPKat’ in the registration form. The upcoming training courses are listed here.
Intellectual Property and Licensing for Life Sciences and Pharma – 20th and 21st September 2023
The course will discuss the key IP rights and associated agreements, with a particular emphasis on licensing patents in order to provide technology transfer and licensing professionals with an overview of patents, trade marks, design rights and trade secrets in the Life Sciences and Pharma field. It is possible to find more information here.
Protecting Confidential Information, Trade Secrets and Know How – 4th October 2023
Intended for senior managers in innovative industries responsible for developing new products and services, the course will provide the attendees with the tools to define confidential information, trade secrets and know how, and to identify the legal framework and best way to protect and licence IP rights. More information here.
IP Essentials for Start Ups and SMEs – 11th October 2023
The free webinar analyses the functional basis of the key intellectual property rights linked to Start-Ups and SMEs, in order to help these businesses develop an IP strategy aimed at innovation and at delivering new products and services to the market. More details here.
Freedom to Operate for Life Sciences and Pharma – 25th and 26th October 2023
The 2-day course delivered in the form of webinar will allow the attendees to learn how to identify and deal with third party chemical, biological and device patents in the Life Science and Pharmaceutical Industries. More details are available here.
Intellectual Property For Commercial Lawyers – 8th and 9th November 2023
The course is intended to provide commercial lawyers and IP professionals with an overview of the key IP rights, associated agreements and IP provisions aimed at the protecting of the client’s rights and intellectual property assets. Details and registration here.
IP Essential for Scientists and Engineers – 22nd November 2023
The free webinar will provide scientists and engineers with an introductory overview on the basic IP rights linked to bringing new products and services to the market and on the protection of IPRs in the scientific field. More information about the webinar can be found here.
Tuesday Wonders
Reviewed by Chiara Gallo
on
Tuesday, August 22, 2023
Rating:
Reviewed by Chiara Gallo
on
Tuesday, August 22, 2023
Rating:
Follow the IPKat on LinkedIn 
![[Guest post] EUIPO Second Board of Appeal refers case to Grand Board of Appeal following earlier refusal to register a photograph of a man’s head/face as an EU trade mark](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEiUj9v-k3DYaSVMR4lsmKDLHVB5nIoINuvZNbH2TQCelrfaAE9qmGSAQs-plzQ7HnZ7Svk_gRdrIODp0Nat5vpWajduit3xkArNhK76AHhX770RIJ62thfCVI5fnvcXU-5zH4NkUSfPY9FjRMFiK7OKJ7m7YSo2FzhyPSoA8ZWCsxaOXb0bBCoPQA/s72-c/Picture%201.png)
![[Guest post] Benelux Office rules on opposition proceedings prepared by ChatGPT](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEi29VY0rNNP1Hqyz8RgB47r4q7fhqQfYHxsEbX_RKmT4KU5Y_vg7vB6dsAW91CidjMfJ38klTvD4mMtZb3QmwFPAHaGF88BPttWSbfYvo7UUg7MpFRTNtEjThmG0QaX2qZFFHSnN71i3YQZSBFC0SL7PgkAlme-XH8cSNWRFbOAOuLr_LMOGcImLQ/s72-c/Screenshot%202024-12-04%20at%2020.45.58.png)
Posts
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html